Prevalencia y caracterización de pacientes con esteatosis hepática en una Unidad de Medicina Preventiva: Estudio observacional, de corte transversal

Simple item page
dc.coverageDOI: 10.4067/s0034-98872024000200187
dc.creatorPérez-Valenzuela, Javier
dc.creatorAguirre, Herman
dc.creatorMartínez, Luz
dc.creatorCastro, Lorena
dc.creatorMezzano, Gabriel
dc.date2024
dc.date.accessioned2025-11-18T19:52:49Z
dc.date.available2025-11-18T19:52:49Z
dc.description<p>Background: Steatotic Liver Disease is the most frequent chronic hepatic disease worldwide. Its prevalence is 30-38% and is associated with progression to steatohepatitis, fibrosis, cirrhosis, and Hepatocellular Carcinoma. A new terminology for this condition was recently published, classifying it into five groups. Aim: To evaluate the prevalence and the association of Steatotic Liver Disease with clinical and laboratory variables in a Preventive Medicine Unit. Methods: A cross-sectional and descriptive study. Patients over 18 years of age, with or without chronic diseases, who consulted the Preventive Medicine Unit of the Clínica Universidad de los Andes between February 2022 and March 2024 were included. Demographic, clinical, laboratory, and imaging data were collected. A hepatic steatosis diagnosis was made using abdominal ultrasound. Results: 4535 patients were included in the analysis; the mean age was 45.1 years, and 37.4% were women. 1214 patients (26.8%) met criteria for hepatic steatosis, who were older (p&lt;0.001) and had a higher proportion of male sex than healthy patients (p&lt;0.001). 94.3% met the criteria for hepatic steatosis associated with metabolic dysfunction; 3.2% met the criteria for metabolic dysfunction and alcohol consumption; 0.5% met the criteria for hepatic steatosis associated with alcohol consumption; and 2.0% met the criteria for cryptogenic hepatic steatosis or due to another cause. Conclusions: The prevalence of hepatic steatosis in our sample was 26.8%, with a significant difference between men and women. In 94.3% of cases, it was associated with metabolic dysfunction.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/114988ee-783d-443a-82d8-cfd8cdf7afbd
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/57910
dc.languagespa
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.sourcevol.152 (2024) nr.2 p.187-196
dc.subjectCross-sectional studies
dc.subjectLiver diseases
dc.subjectNon-alcoholic fatty liver disease
dc.subjectPrevalence
dc.subjectPreventive medicine
dc.titlePrevalencia y caracterización de pacientes con esteatosis hepática en una Unidad de Medicina Preventiva: Estudio observacional, de corte transversalspa
dc.titlePrevalence and clinical associations of steatotic liver disease in a Preventive Medicine Unit: A cross-sectional studyeng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE